Koulin Chou, MD
Dermatology · Voorhees, NJNPI 1588757165
Payments from drug & device makers
Across 39 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Journey Medical Corporation$71
- Regeneron Healthcare Solutions, Inc.$66
- Amgen$59
- Kerecis Limited$54
- Pfizer$54
- Mayne Pharma Commercial LLC$47
- plus $308 from 14 others
What the payments were for
- Food & beverage$659100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Journey Medical Corporation | 1 | $71 |
| Regeneron Healthcare Solutions, Inc. | 4 | $66 |
| Amgen | 4 | $59 |
| Kerecis Limited | 3 | $54 |
| Pfizer | 4 | $54 |
| Mayne Pharma Commercial LLC | 2 | $47 |
| Sun Pharmaceutical Industries Inc. | 2 | $41 |
| Novartis | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Glenmark Therapeutics Inc. | 4 | $31 |
| EPI Health, LLC | 2 | $30 |
| VYNE Pharmaceuticals Inc. | 1 | $24 |
| Sebela Pharmaceuticals Inc. | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $17 |
| UCB, Inc. | 1 | $15 |
| LEO Pharma Inc. | 1 | $14 |
| Biofrontera Inc. | 1 | $14 |
| AbbVie | 1 | $12 |
| Organon | 1 | $3 |
How this compares
$659 in reported general payments places this provider in the 25th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 121 | $7,409 |
| Ciclopirox | 80 | $1,957 |
| Mupirocin | 253 | $1,519 |
| Ketoconazole | 56 | $1,412 |
| Triamcinolone Acetonide | 111 | $888 |
| Cephalexin | 51 | $737 |
| CiclopiroxCiclopirox Olamine | 12 | $653 |
| Clobetasol Propionate | 16 | $550 |
| Clindamycin Phosphate | 34 | $400 |
| Amoxicillin | 149 | $355 |
| Nystatin | 12 | $251 |
| KlayestaNystatin | 13 | $224 |
| Hydrocortisone | 49 | $167 |
| Azithromycin | 28 | $75 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Voorhees
- Ronald BernardinVoorhees$688K
- David FinkelsteinVoorhees$21K
- Jerry BagelEast Windsor$15.4M
- Jonathan DosikGlen Rock$8.4M
- Omar NoorSomerset$4.6M
- Linda Cappiello-LindsleyHoboken$2.3M
- Winston MoyDenville$1.8M
- Brian KeeganEast Windsor$1.7M
- Jeanine DownieMontclair$1.2M
- Adolfo Fernandez ObregonHoboken$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.